Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

BHP FY profits sink to five-year low

(Sharecast News) - Mining giant BHP said on Tuesday that full-year profits had fallen to a five-year low, with sluggish demand from China weighing on iron ore prices. BHP posted a 26% drop in underlying profits to $10.16bn, below consensus estimates of $10.22bn and the lowest since 2020's Covid-impacted trading year, while revenues dropped 8% to $51.26bn due to the impact of lower iron ore prices and weakness in steelmaking coal markets.

BHP also paid its lowest dividend in eight years, although its final dividend of $0.60 per share, down from $0.74 a year earlier, was higher than anticipated, reflecting lower debt and the disposal of non-core assets in Brazil.

The FTSE 100-listed group stated copper production helped offset weakness in other commodities, making up 45% of the company's underlying earnings. On the other hand, average realised prices for iron ore fell 19%.

BHP also raised its net debt target range to $10bn-20bn, up from between $5bn and $15bn, stating the decision follows technical analysis.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.